High-tech rehabilitative treatment: Virtual Reality (e.g., VRRS Evo): Provides an engaging and immersive environment for cognitive and motor exercises. Stabilometric Platform (e.g., Gea Master or Prokin Technobody): Used for balance and postural control training. Treadmill System (e.g., Walkerview Technobody): Used for aerobic exercises with gait analysis and feedback
Rehabilitation: Traditional rehabilitative treatment
The primary objective is to demonstrate, in a population of chronic neuromuscular disease the non-inferiority of a rehabilitation treatment integrated with robotic and/or technological devices compared to traditional rehabilitation treatment in the level of fatigue.
The main question it aims to answer is:
Are high-tech rehabilitation interventions, including robotic systems, virtual reality, and stabilometric platforms, not inferior to traditional rehabilitation methods in improving balance, motor function, fatigue levels, sarcopenia, cognitive engagement, and overall quality of life in patients with chronic neuromuscular diseases (NMDs)? Researchers will compare a robotic treatment group, that consists in an high-tech rehabilitation, with a control group, that will receive the traditional rehabilitative treatment.
| Facility | City | Region | Status |
|---|---|---|---|
| IRCCS Azienda Ospedaliera Universitaria San Martino - Genova | Genova | Italy | Not Yet Recruiting |
| Istituti Clinici Scientifici Maugeri IRCCS, Milan Institute | Milan | Italy | Recruiting |
| Azienda Ospedaliero-Universitaria di Modena | Modena | Italy | Not Yet Recruiting |
| Istituti Clinici Scientifici Maugeri | Montescano | Italy | Not Yet Recruiting |
| Istituti Clinici Scientifici Maugeri IRCCS | Pavia | Italy | Not Yet Recruiting |
| Fondazione Don Carlo Gnocchi Onlus | Roma | Italy | Not Yet Recruiting |
| Istituti Clinici Scientifici Maugeri IRCCS | Telese Terme | Italy | Not Yet Recruiting |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06881979 on ClinicalTrials.gov ↗ ← All trials in Italy